NCT03914534View on ClinicalTrials.gov

Bioequivalence Study of Sodium Divalproate Tablets 500 mg

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 17, 2017

Primary Completion Date

July 31, 2018

Study Completion Date

February 12, 2019

Conditions
Healthy
Interventions
DRUG

Valproic Acid 500 MG

Administration of 500 mg of Valproic Acid

DRUG

Valcote 500 mg

Administration of 500 mg of Valproic Acid

Trial Locations (1)

Unknown

Universidad de la Sabana, Chía

All Listed Sponsors
lead

Tecnoquimicas

INDUSTRY

NCT03914534 - Bioequivalence Study of Sodium Divalproate Tablets 500 mg | Biotech Hunter | Biotech Hunter